Changing the Culture of the FDA Act

S 604, the "Changing the Culture of the FDA Act," requires the FDA to update its mission statement to explicitly include protecting public health by "strongly considering the danger of addiction and overdose death" when approving or regulating opioid medications. This bill directly affects the FDA's decision-making process for opioid-related drugs, mandating that addiction and overdose risks be a central factor in its reviews. The key provision is the formal amendment to the agency's mission statement, which would reshape how the FDA prioritizes public health considerations in opioid policy. The bill does not create new regulations but changes the foundational guidance for the agency's work on opioids.